We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
31 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JEXT JNR 150 adrenaline (epinephrine) (as acid tartrate) 150 microgram/0.15 mL solution for injection pre-filled cartridge (auto-injector).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JEXT 300 adrenaline (epinephrine) (as acid tartrate) 300 microgram/0.3 mL solution for injection pre-filled cartridge (auto-injector).
-
Australian public assessment report (AusPar)Vaxchora (vibrio cholerae vaccine) was approved for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older travelling to cholera-affected countries.
-
Australian public assessment report (AusPar)Nuvaxovid (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 vaccine has been approved for the prevention of coronavirus disease 2019 (COVID-19) caused by SARSCoV-2 in individuals 12 years of age and older.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Vaxchora Vibrio cholerae bacteria cells (CVD 103-HgR strain) 4 x 10^8 to 2 x 10^9 CFU suspension, powder for, sachet.
-
Australian public assessment report (AusPar)Nuvaxovid (SARS-CoV-2-rS), a vaccine against SARS-CoV-2, has been approved for the prevention of COVID-19.
-
Prescription medicine decision summaryVaxchora (vibrio cholerae) is approved to prevent disease caused by Vibrio cholerae serogroup O1 in those travelling to cholera-affected countries.
-
Prescription medicine registrationActive ingredients: Vibrio cholerae.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NUVAXOVID (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 VACCINE adjuvanted suspension for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Biocelect Pty Ltd - Red cell metabolic enzyme IVDs.